GI Flashcards
causes of regurgitation
increased intragastric pressure
decreased LES tone
drugs that decrease LES tone
atropine glycopyrrolate dopamine nitroprusside thiopental tricyclic antidepressants B-adrenergic stimulants inhaled anesthetics opioids propofol
severity of aspiration
pH
amount
type of aspirate
pretreatment for patients at risk for aspiration
reglan
h2 antagonists
non-particulate antacid
reglan (metoclopramide)
increases LES tone and gastric emptying, anti-emetic (dopamine receptors)
10-20 mg IV over 3-5 minutes, 15-30 minutes before induction
avoid in Parkinsons, SBO, seizure disorder
non-particulate antacid (sodium citrate/citric acid/bicitra)
increased gastric pH and volume
30 ml 15-30 minutes before induction
avoid in renal failure patient
H2 antagonists: cimetidine (Tagamet) famotidine (Pepcid) ranitidine (Zantac) Nizatidine (acid)
blocks H2 receptors
cimetidine (Tagamet)
300 mg IVPB
inhibits CYP450 and decreases hepatic blood flow
famotidine (Pepcid)
20 mg IV
ranitidine (Zantac)
50 mg IVPB
proton pump inhibitors omeprazole (Prilosec) lansoprazole (Prevacid) pantoprazole (protonix) esomeprazole (nexium)
inhibit secretion of H+ ions by parietal cells
*caution with malabsorption of other drugs
Nausea Receptors
vestibular system
chemoreceptor trigger zone: dopamine, histamine, serotonin, acetylcholine
Dopamine Antagonists
REGLAN (benzamides)
DROPERIDOL (butyrophenones): 0.625-1.25 mg IV over 2-5 minutes, black box warning for QT prolongation
peripheral alpha antagonist = vasodilatation
can cause extrapyramidal side effects, contraindicated in Parkinson’s disease
Serotonin Antagonists
ZOFRAN: 4 mg
DOLASETRON: 12.5 mg
GRANISETRON: 0.35-1 mg
PALONOSETRON: 0.075 mg *long acting
*avoid Zofran with QT prolongation
Histamine Antagonists
BENADRYL: 25-50 mg q4-6 hours
DRAMAMINE
Anticholinergics
SCOPOLAMINE: 1.5 mg patch for 3 days
apply the night before surgery
Corticosteroids
DECADRON: 4-8 mg IV, mechanism unknown, contraindicated in diabetics and cancer, most efficacious if given prior to induction, reduces pain
Neurokinin 1 Receptor Antagonist
EMEND: inhibits receptor, metabolized by CYP 450, 40 mg IV 3 hours prior to induction
risk factors PONV
female age>50 history of PONV high doses of opioids surgery >1 hour laparoscopic procedures
risk factors PDNV
female
age>50
history of PDNV
PONV